Y. Abe

发表

Nonpeptide mimic of bradykinin with long-acting properties at the bradykinin B2 receptor.

K. Nakahara, T. Inoue, Y. Notsu, 1997, Molecular pharmacology.

Nonpeptide mimic of bradykinin with long-acting properties.

K. Nakahara, T. Inoue, Y. Notsu, 1999, Immunopharmacology.

Pharmacological characterization of a novel, orally active, nonpeptide bradykinin B2 receptor antagonist, FR167344.

K. Nakahara, T. Inoue, H. Kayakiri, 1997, European journal of pharmacology.

The identification of an orally active, nonpeptide bradykinin B2 receptor antagonist, FR173657

K. Nakahara, M. Okuhara, H. Kayakiri, 1997, British journal of pharmacology.

Stereocontrolled Total Synthesis of (5Z,8Z,10E,12R,14Z)-12-Hydroxy-5,8,10,14-icosatetraenoic Acid [(12R)-HETE]

K. Nicolaou, J. Ramphal, Y. Abe, 1989 .

Stereocontrolled Total Synthesis of Lipoxins As and B5

K. Nicolaou, S. Webber, J. Ramphal, 1987 .

Orally available pyridinylpyrimidine derivatives as novel RANKL-induced osteoclastogenesis inhibitors.

M. Takeuchi, Toshihiro Watanabe, M. Ohkubo, 2012, Bioorganic & medicinal chemistry letters.

Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997

K. Nakahara, T. Inoue, H. Kayakiri, 1998, British journal of pharmacology.

Bridging of macrodithionolactones to bicyclic systems. Synthesis and modeling of oxapolycyclic frameworks

J. Snyder, K. Nicolaou, P. Carroll, 1990 .

Discovery of orally active nonpeptide bradykinin B2 receptor antagonists.

K. Nakahara, H. Kayakiri, N. Inamura, 1999, Immunopharmacology.

Total Synthesis of Brevetoxin B. 1. First Generation Strategies and New Approaches to Oxepane Systems

K. Nicolaou, E. Theodorakis, K. B. Reddy, 1996 .

Discovery of the first non-peptide full agonists for the human bradykinin B(2) receptor incorporating 4-(2-picolyloxy)quinoline and 1-(2-picolyl)benzimidazole frameworks.

I. Aramori, H. Kayakiri, N. Inamura, 2004, Journal of medicinal chemistry.

A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 3. Discovering bioisosteres of the imidazo[1,2-a] pyridine moiety.

T. Inoue, I. Aramori, H. Kayakiri, 1998, Journal of medicinal chemistry.

A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 1. Construction of the basic framework.

T. Inoue, H. Kayakiri, N. Inamura, 1998, Journal of medicinal chemistry.

Regio-, stereo-, and enantioselective synthesis of cyclobutanols by means of the photoaddition of 1,3-dioxin-4-ones and lipase-catalyzed acetylation☆☆☆

Masayuki Sato, C. Kaneko, Y. Abe, 1992 .

Use of 1,3-dioxin-4-ones and their related compounds in synthesis. Part 28 . Asymmetric de mayo reactions using chiral spirocyclic dioxinones

T. Furuya, Masayuki Sato, C. Kaneko, 1991 .

1,3‐dioxin‐4‐ones as versatile intermediates for organic synthesis

Masayuki Sato, C. Kaneko, Y. Abe, 1990 .

Total synthesis of the depsipeptide FR-901375.

K. Janda, P. Wentworth, Y. Abe, 2003, The Journal of organic chemistry.

A new class of nonpeptide bradykinin B(2) receptor ligand, incorporating a 4-aminoquinoline framework. Identification of a key pharmacophore to determine species difference and agonist/antagonist profile.

I. Aramori, H. Kayakiri, N. Inamura, 2004, Journal of medicinal chemistry.

A new series of highly potent non-peptide bradykinin B2 receptor antagonists incorporating the 4-heteroarylquinoline framework. Improvement of aqueous solubility and new insights into species difference.

I. Aramori, H. Kayakiri, N. Inamura, 2004, Journal of medicinal chemistry.

A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 4. Discovery of novel frameworks mimicking the active conformation.

T. Inoue, I. Aramori, H. Kayakiri, 1998, Journal of medicinal chemistry.

Synthesis of Optically Active Cyclopenta[c]pyran-4-carboxylic Acid Derivatives, Building Blocks for Iridoids. An Attractive Alternative to Asymmetric de Mayo Reaction

T. Furuya, Masayuki Sato, C. Kaneko, 1989 .

Bridging of Macrodithionolactones to Bicyclic Systems. Synthesis and Modeling of Oxapolycyclic Frameworks.

J. Snyder, K. Nicolaou, P. Carroll, 1990 .

Stereocontrolled Total Synthesis of (5Z,8Z,10E,12R,14Z)-12-Hydroxy-5,8,10,14-icosatetraenoic Acid [(12R)-HETE]

K. Nicolaou, J. Ramphal, Y. Abe, 1990 .